.png)
Regenerative Clinic
YOUR STEM CELL THERAPY PROVIDER
ABOUT US
FULLY AUTOMATIC ARTIFICIAL INTELLIGENCE STEM CELLS CULTURING ROBOT.
Robotic StemCell BioTech Ltd. possesses the licensing rights to distribute a fully automated artificial intelligence stem cell culturing robot. This state-of-the-art technology represents a pioneering breakthrough, as it requires only one professional to oversee the entire culturing process, setting it apart from other comparable machines currently available in the market that are only semi-automated and reliant on more manpower.
​
Additionally, we have secured the licensing agreement for the intellectual properties of the stem cell therapy from our reputable hospitals in Japan. This serves as a testament to our dedication to advancing the field of regenerative medicine and providing our clients with the highest quality products and services.
Who are we?
Our organization has formed valuable partnerships with esteemed institutions, including Japanese National Hospitals, members of the Hong Kong SAR Department of Health, and the sole medical institution in Asia to have established a stem cell treatment center and set the standard in the field.
We take great pride in being recognized as a professional organization that offers top-notch stem cell therapy and medical tourism services. Our commitment to upholding the highest standards of professionalism and integrity is reflected in our provision of state-of-the-art equipment, exceptional service, and superior medical care to our valued clients.
_edited.jpg)
Our organization is dedicated to providing a range of regenerative medicine services that contribute to your overall health and well-being. Our commitment to excellence is reflected in our use of cutting-edge disease management techniques and industry-leading products and technologies.
​
Whether you require treatment for immune system disorders, anti-aging therapies, or oncological diseases, we are your ideal partner. With our expertise and advanced resources, we are equipped to provide you with the best possible solutions to meet your unique needs and promote optimal health.
MEDICAL SYSTEM IN JAPAN
THE WORLD'S LEADING ADVANCED MEDICAL COUNTRY
Japan is widely recognized as one of the world's leading countries in terms of longevity, with its citizens boasting the highest average life expectancy and healthy life expectancy. According to 2018 statistics, the average life expectancy for Japanese women is 87.32 years and for men, it is 81.25 years. In addition, the average healthy life expectancy is 74.79 years for women and 72.14 years for men, placing Japan in first place globally. This impressive achievement is attributed to Japan's advanced medical system, high level of health care awareness, and cutting-edge diagnostic technology.
​
In 2018, the World Health Organization released a comprehensive global medical assessment report, evaluating and ranking over 190 countries based on their medical infrastructure, accessibility to medical services, and fairness of medical expenses. Once again, Japan emerged as the top-ranked country in the world.
​
Not only has Japan earned its reputation as a leader in longevity, but its medical care is also held in high regard worldwide. According to The Conference Board of Canada, Japan received the highest possible grade in mortality rates for cancer, circulatory disease, diabetes, musculoskeletal disease, mental illness, infant care, medical malpractice, and more. Out of the 48 developed countries, Japan ranks first in these categories, a testament to the country's commitment to providing top-quality medical care for its citizens.
MEDICAL ADVANTAGES IN JAPAN
CANCER TREATMENT (RADIATION THERAPY)
Heavy ion beam therapy, proton beam therapy, boron neutron capture therapy (BNCT), and localized radiation therapy have fewer side effects than traditional radiation therapy. Heavy ion beam therapy for cancer is a successful technique pioneered by Japan and is now widely recognized.
CANCER TREATMENT (NON-RADIATION)
In Japan, endoscopic treatment for a direct excision of the lesion without surgery, laparoscopic surgery or thoracoscopy surgery through an incision in the abdomen or chest, arthroscopic surgery, endoscopic mucosal dissection, resection are supported by a digital image diagnosis system. The development of a digital image diagnosis system is to target the disease at the molecular level as early as possible, whether it is to formulate a treatment plan or to successfully carry out treatment experience for patients, Japan ranks the highest in the world.
REGENERATIVE MEDICINE
In Japan, in the field of regenerative medicine to reconstruct lost organs or tissue, clinical studies have been carried out using individual cell membrane culture (membrane-like material grown from patients' cells) for the treatment of cardiac insufficiency and corneal transplantation.
CARDIOVASCULAR NEUROSURGERY
In Japan, percutaneous coronary angioplasty (PTCA), which can reduce the physical burden of patients, has accounted for 70% of cardiovascular treatment, far exceeding traditional surgical treatment. With the development of medical equipment technology, this treatment will shorten heart surgery and the period of recovery. Many cranial nerve surgery patients who are rejected by other countries have come to Japan for surgery.
ORGAN TRANSPLANTATION
Almost all liver transplants in Japan are partial liver transplants from living donors and its 5-year survival rate ranks among the best in the world. Furthermore, Japan ranks the best in terms of infection prevention during the entire transplant process, especially after surgery.
OPHTHALMOLOGY
Through prevention and treatment, the blindness rate in Japan is only 0.14%, which is the lowest in the world. Targeted comprehensive ophthalmology examination, rich treatment experience, and the clinical application of corneal regenerative medicine in recent years have made Japan a world leader in the field of ophthalmology.
ORTHOPEDICS
Using bone materials tailored to individual skeletal characteristics, artificial joints are specially tailored to Asian skeletal characteristics, enabling each patient to receive the best possible treatment.
OBSTETRICS AND GYNECOLOGY
Japan is the world's largest infertility country, with an average of 240,000 in vitro fertilizations per year, the highest in the world.
TREATMENT PROGRAMS
TYPE I AND TYPE II DIABETES (NON-ADVANCED)
KIDNEYS (CHRONIC KIDNEY DYSFUNCTION, ETC.)
LIVER (HEPATITIS, CIRRHOSIS)
ANTI AGING
LUNGS (INTERSTITIAL PNEUMONIA)
HEART (MYOCARDIAL INFARCTION)
SPINAL CORD INJURY
BRAIN (STROKE, ALZHEIMER'S DISEASE PREVENTION)
ANTI-AGING OF JOINTS AND MUSCLES, REPAIR OF CARTILAGE TISSUE
STEM CELL INFERTILITY TREATMENT (DEPENDING ON THE SPECIFIC CONDITION
NK,NKM CELL IMMUNOTHERAPY (FOR CANCER REHABILITATION AND PREVENTION, EXCLUDING LEUKEMIA AND LYMPHOMA AND BONE MARROW RELATED CANCERS)
WHY US?
STEM CELL THERAPY REFERRAL TO JAPAN
"Regenerative medicine" is known as the world's most advanced treatment method. Throughout the major medical advanced countries in Europe and the United States, there are only a handful of medical institutions capable of implementing this method.
​
Among these few medical institutions, the medical centers we refer are the top medical institutions recognized by the industry. During the referral process, we take a full range of services from comprehensive health consultation → harvesting cells → cell culture → putting them back into the body → follow-up diagnosis and treatment.
Our partnership hospitals are all in compliance with the Japanese Ministry of Health, which sets the highest standard.
In Japan, there are strict laws regulating all facilities for the implementation of regenerative medicine and mesenchymal stem cell therapy. Our treatment plans for the patients are all fall under the regulations.
CONSULTATION
DISEASE DIAGNOSIS
Consultation with accredited regenerative medicine physicians and consultants to determine the patient's underlying condition.
We will make a diagnosis report based on the patient's disease before referral, in order to ensure that the referral hospitals in Japan will accept the case. The treatment hospitals we provide are National Cancer Institute, Ariake Cancer Institute, Shuntendo, Mita, and National International. If the hospital refuses to accept the case, we will directly refuse the patient to avoid wasting time and money. If the patient conceals the basic situation, we will stop the treatment directly after confirmation by our doctor or hospital.
HOSPITAL REFERRAL
CANCER TREATMENT
This information will be passed on to our subsidiary in Japan and the patient's condition will be studied. Depending on the type and condition of the illness, we will recommend one or more hospitals that can provide treatment and will submit the required documents to the hospital.
​
medical records
lab testing
pet-ct inspection, etc.
​
​
The following conditions are not suitable for stem cell cancer treatment:
​
Has had cancer surgery in Japan for the same cancer disease and will not undergo surgery for two years after surgery.
Breast cancer recurrence is unacceptable.
Recurrence of the same cancer within five years is unacceptable.
In the above-mentioned patients, if they know that the treatment is ineffective and they only want life-extending treatment, we can offer life-extending treatment. If the situation is accepted, various disclaimers must be signed before departure from Japan and the required fee shall be subject to the actual situation.
FAQs
YOUR QUESTIONS ANSWERED
How much is the fee for treatment?
The patient is required to confirm the intent to disclose the information and pay for the treatment listed below. Fees are non-refundable and need to be declared by the patient.
​
Japanese translation of medical records: Approx. 1,730 USD (200,000 YEN)
Referring to the attending doctor of the hospital for review of medical records: Approx. 2,165 USD - 4,330 USD (250,000 - 500,000 YEN)
Administrative fee: Approx. 1,730 USD - 2,600 USD (200,000 - 300,000 YEN)
If the patient is successfully referred, we will charge a medical fee of approx. 69,330 USD (8 million YEN), which does not include any follow-up services.
If the patient needs more than one treatment of the same type, the follow-up medical fee is approx. 34,667 USD (4 million YEN) per treatment.
This fee is payable before the patient travels to Japan for treatment.
For health treatment (non-disease treatment such as anti-aging), the first treatment fee is approx. 52,000 USD |(6 million YEN) and then approx. 34,667 USD (4 million YEN) is charged each time.
If a Japanese hospital accepts a case, the cost of treatment will be 300-400% of the cost of a Japanese resident. The reason is that foreign residents do not have medical insurance paid by the Japanese government on their behalf. The hospital will bill the patient directly for the original price of the treatment. The same cancer treatment costs half as much in Japan as in the United States.
We can only apply to one hospital at a time, and can only apply to the second hospital after being rejected by the first hospital. This process is to avoid more than one hospital admitting patients at the same time.
Will IÂ receive the report from the medical team before making the decision to obtain the treatment?
We will deliver the translated information to Japanese hospitals within 1 week. The Japanese hospital will arrange for a doctor to review the case within a week. The hospital will send a review summary report within two weeks. Additionally, the hospital will decide whether to accept the case.
What else I can do if you refuse to refer after the medical review?
If the Japanese hospital rejects the case, the patient will be notified of the rejection result. If the patient wishes to proceed to the next hospital, we will charge the next hospital's submission fee. The Japanese hospital will issue a review report and receipt within two weeks. Services will be terminated if the patient abandons or our partner hospital cannot be admitted.
If there is a hospital accept my file, what is the next step?
If the Japanese hospital accepts the case, we will notify the patient of the acceptance result, the Japanese hospital will issue a review report and a receipt and we will coordinate with the patient and the hospital to seek medical treatment in Japan. Depending on the rules of each hospital, patients may be required to pay a deposit to travel to Japan for treatment. The deposit will be deducted during the treatment period and the hospital will also issue a clear receipt to reassure the patient.
Any further issues I need to be aware of before I depart?
Patients need to arrive at the hospital on their own on the date designated by the Japanese hospital. We will arrange for a professional medical translator to contact the patient in advance and follow up with the patient for three days free of charge. If the patient needs to continue to use the professional medical translation service afterwards, the medical translation fee is 60,000 YEN/8 hours and 40,000 YEN/4 hours. Some hospitals will appoint their own medical interpreter. The translation fee depends on the hospital's regulations. If the patient hires a medical translator by himself, our company does not limit it. However, patients need to know that the company is not responsible for all consequences (such as unqualified medical translation, random translation, etc.) caused by hiring medical translators by themselves.
What type of VISA I need?
If the patient is receiving treatment in Japan for more than three months, a medical visa needs to be applied for under Japanese law. After the patient is admitted to a Japanese hospital, we will send a specialist to arrange a medical visa. The fee is 300,000 YEN, to avoid problems during handover, please use our service.
What is the responsibility of Robotic StemCell BioTech LTD. from this medical referral?
After the patient is admitted to the ward, our responsibility is fulfilled. We will issue a document to confirm that. If the patient has other issues, he can entrust us to provide additional services.
Any optional services could be provided by your company? Such as pick up service at the airport?
Charges for optional items:
​
NARITA AIRPORT ONE-WAY HOTEL PICKUP (35,000 YEN)
HANEDA AIRPORT ONE-WAY HOTEL PICKUP (30,000 YEN)
SHORT-TERM RENTAL OF LOCAL APARTMENTS IN JAPAN. (ASK FOR QUOTE)​​
DAILY TRANSPORTATION SERVICE: 60,000 YEN PER DAY, FUEL AND TOLL FEE EXTRA.